2021
DOI: 10.1016/j.bpc.2021.106665
|View full text |Cite
|
Sign up to set email alerts
|

Kinetics theories to understand the mechanism of aggregation of a protein and to design strategies for its inhibition

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
17
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 35 publications
(20 citation statements)
references
References 176 publications
0
17
0
Order By: Relevance
“…Our research provides a new biophysical tool for investigating the oligomerization and aggregation of SOD1. , First, our work shows that the corkscrew-like intermediate is an early-on on-pathway species and can stabilize for a period of time. Thus, using the same approach, we can investigate how this corkscrew-like intermediate interacts with the cell membranes from the perspective of the Trp side chains and the backbones, providing a molecular picture to understand the toxicity of the intermediate.…”
Section: Resultsmentioning
confidence: 85%
“…Our research provides a new biophysical tool for investigating the oligomerization and aggregation of SOD1. , First, our work shows that the corkscrew-like intermediate is an early-on on-pathway species and can stabilize for a period of time. Thus, using the same approach, we can investigate how this corkscrew-like intermediate interacts with the cell membranes from the perspective of the Trp side chains and the backbones, providing a molecular picture to understand the toxicity of the intermediate.…”
Section: Resultsmentioning
confidence: 85%
“… 5–8 Knowledge about their structures and assembly pathways is crucial for understanding Aβ oligomerization mechanisms, the molecular basis of AβO toxicity, and its interplay with other aggregation diseases, 9 based on which aggregation inhibition strategies may be designed. 10,11 There are two major Aβ alloforms that contain 40 and 42 amino acids, respectively. Aβ42, which has two more amino acids at the C-terminus, oligomerizes more easily and is more neurotoxic.…”
Section: Introductionmentioning
confidence: 99%
“…In particular, the structural intermediates evolving during the aggregation process which have been assessed as being the key malign species are highly transient and diversified rendering them a scientific subject that features even more obscurity and necessitates further investigation and research. Any structural information about the Aβ peptide conversion into oligomers and finally fibrils is considered crucial for developing new strategies for tackling AD [ 3 , 4 , 5 ].…”
Section: Introductionmentioning
confidence: 99%